The Yale Innovation Summit is a day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community.

Check out the 2017 Event Program!

Held at Yale School of Management, and presented by the Office of Cooperative Research and the Yale Entrepreneurial Institute, last year’s event featured more than 350 attendees including faculty members, local industry executives, students and post-docs.  Additionally, over 50 venture capital investors were represented from over 25 firms that in aggregate had over $40 billion under management. This was the most significant gathering of venture investors ever on Yale’s campus.


5AM Ventures, Atlas Venture, Elm Street Ventures, Abbvie Ventures, Evolution Life Science Partners, F-Prime Capital Partners, Bulldog Innovation Group, Chart Venture Partners, Nyca Partners, OrbiMed, Polaris Partners, Thayer Street Partners, Vital Venture Capital, New Enterprise Associates, Oak HC/FT, New Leaf Venture Partners, Golden Seeds, Pickwick Capital Partners, Samsung Ventures, Polaris Partners, Axiom Venture Partners, Sanofi-Genzyme BioVentures, LifeSci Capital, Maverick Ventures, Eight Seven Capital, Greater Good Ventures, Trillium Medical Ventures, Blue Ivy Ventures, Fairview Capital Partners, Velocity Fund Partners, Johnson & Johnson, Novartis Venture Funds, Hercules Capital, Agent Capital, Lockheed Martin Ventures & Morningside Group


  • Rob Bettigole, Managing Partner, Elm Street Ventures
  • Kevin Bitterman, Partner, Polaris Partners
  • Christine Brennan, Principal, Novartis Venture Funds
  • Erdogan Cesmeli, Executive Director, GE Ventures
  • Gerald Chan, Cofounder, Morningside Group
  • Christopher J. Denn, Partner, Goodwin
  • Jason Hafler, Senior Director of Investments, Sanofi-Genzyme BioVentures
  • Roy Herbst, Associate Director for Translational Research, Yale Cancer Center
  • Paul Hermes, Entrepreneur-in-Residence, Medtronic
  • Paul Hughes, Partner, Wiggin & Dana
  • Jim Hornthal, Chairman, M34 Capital, Zignal Labs
  • Hyuk Jeen-Suh, Head of Samsung Ventures East Coast
  • Ken Kaufmann, VP Marketing, Hamamatsu
  • Patricia Kemp, General Partner, Oak HC/FT
  • Chau Khuong, Private Equity Partner, OrbiMed
  • Stephen Knight, President and Managing Partner, F-Prime Capital Partners
  • Kathleen McGroddy-Goetz, VP, Partnerships & Solutions, IBM Watson Health
  • Chris McLeod, Managing Partner, Elm Street Ventures
  • Chris Moran, VP & GM at Lockheed Martin Ventures
  • Sara Nayeem, Partner, New Enterprise Associates
  • Lili Portilla, Director of Office Strategic Alliances, NCATS
  • Liam Ratcliffe, Managing Director, New Leaf Venture Partners
  • Jeffrey Reitman, Principal, Nyca Partners
  • Jason Rhodes, Partner, Atlas Venture
  • Helge Seetzen, General Partner, Tandem Launch
  • Stephen Squinto, Venture Partner, OrbiMed
  • Mary Tanner, Senior Managing Director, Evolution Life Science Partners
  • Lou Tartaglia, Executive-in-Residence, 5AM Ventures
  • James Tobin, Vice President, Cardiovascular and Metabolism Scientific Innovation, Johnson & Johnson
  • Jarrod Yuster, CEO, Pico Quantitative Trading


Yale Innovation Summit to Feature Leading Investor and Philanthropist Gerald Chan

The Yale Innovation Summit will feature Gerald Chan as a keynote speaker. Chan is the cofounder of Morningside Group—a private equity and venture capital firm that has invested in a number of biotech companies—and a noted philanthropist. He donated $350M to Harvard, his alma mater, for the renamed Harvard T.H. Chan School of Public Health—the largest such gift in the university’s history. READ MORE.